GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Jun 30, 2022

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-22-000013General Corporate
Debt relative to revenue87thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.debt_to_revenue

515.12% · OPTIONAL · VALID

Capex intensity33thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.21% · OPTIONAL · VALID

Operating cash generation93thOwn-history percentile · N=14
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

26.51% · OPTIONAL · VALID

Revenue growth18thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.revenue

-7.97% · CORE · VALID

Inventory pressure33thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

113.34% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.gross_margin

58.88% · CORE · VALID

R&D intensity7thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

6.97% · OPTIONAL · VALID

SBC intensity57thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.44% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
500.73%
Current
515.12%
Delta
14.39%
Capex Intensity Increased
Previous
1.55%
Current
2.21%
Delta
0.66%
Cash Generation Increased
Previous
-5.06%
Current
26.51%
Delta
31.57%
Growth Decreased
Previous
-1.37%
Current
-7.97%
Delta
-6.61%
Inventory Pressure Increased
Previous
109.80%
Current
113.34%
Delta
3.54%
Margin Increased
Previous
58.45%
Current
58.88%
Delta
0.43%
R And D Intensity Increased
Previous
6.61%
Current
6.97%
Delta
0.35%
Sbc Intensity Increased
Previous
1.14%
Current
1.44%
Delta
0.30%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN MARGIN_INCREASED →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ELAN CAPEX_INTENSITY_INCREASED →Transitioned To · ELAN CASH_GENERATION_INCREASED →Transitioned To · ELAN GROWTH_DECREASED →Transitioned To · ELAN INVENTORY_PRESSURE_INCREASED →Transitioned To · ELAN R_AND_D_INTENSITY_INCREASED →Transitioned To · ELAN SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.